In a large multicenter cohort, dual antiplatelet therapy showed the greatest 90 day benefit when started within 24 hours ...

The language used to describe either escalation or de-escalation of antiplatelet therapy by modifying the type, dose, or number of medications in patients with coronary artery disease has been ...

"The results of our trial potentially broaden the time window for the initiation of treatment, although there was more bleeding with the dual regimen than with the monotherapy," the authors wrote. In ...

PARIS -- Antiplatelet de-escalation worked well following drug-coated balloon (DCB) placement for acute coronary syndrome (ACS), according to the first randomized trial on this subject. In ...

Please provide your email address to receive an email when new articles are posted on . The efficacy of dual antiplatelet therapy vs. aspirin in patients with stroke was similar when given less than ...

CHICAGO, IL—Data from a new study provide yet more support for the use of single antiplatelet therapy (SAPT) after TAVI, with investigators concluding that dual antiplatelet therapy (DAPT) should be ...

The long-term combination of cilostazol with aspirin or clopidogrel resulted in fewer recurrent strokes than with aspirin or clopidogrel alone in high-risk patients. Stroke survivors taking a ...